These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 14580255)

  • 1. Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer.
    Moadel RM; Nguyen AV; Lin EY; Lu P; Mani J; Blaufox MD; Pollard JW; Dadachova E
    Breast Cancer Res; 2003; 5(6):R199-205. PubMed ID: 14580255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positherapy: targeted nuclear therapy of breast cancer with 18F-2-deoxy-2-fluoro-D-glucose.
    Moadel RM; Weldon RH; Katz EB; Lu P; Mani J; Stahl M; Blaufox MD; Pestell RG; Charron MJ; Dadachova E
    Cancer Res; 2005 Feb; 65(3):698-702. PubMed ID: 15705862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emitting 18F-2-deoxy-2-fluoro-D-glucose: potential hot new therapy.
    Mortimer JE; Taylor ME
    Breast Cancer Res; 2003; 5(6):329-31. PubMed ID: 14580251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model.
    Fang S; Wang J; Jiang H; Zhang Y; Xi W; Zhao C; Tian M; Zhang H
    Cancer Biother Radiopharm; 2010 Dec; 25(6):733-40. PubMed ID: 21204768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapeutic use of 2-deoxy-2-[18F]fluoro-D-glucose--a comment.
    Meyer MA
    Breast Cancer Res; 2004; 6(1):E2. PubMed ID: 14680488
    [No Abstract]   [Full Text] [Related]  

  • 6. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
    Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma.
    Kaarstad K; Bender D; Bentzen L; Munk OL; Keiding S
    J Nucl Med; 2002 Jul; 43(7):940-7. PubMed ID: 12097467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
    Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective radiotherapy of primary tumors and metastasis with 18F-2-deoxy-2-fluoro-D-glucose in C57BL/6 mice.
    Caridad V; Arsenak M; Abad MJ; Martín R; Guillén N; Colmenter LF; Taylor P
    Cancer Biother Radiopharm; 2008 Jun; 23(3):371-5. PubMed ID: 18593370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
    Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
    Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma.
    Hoffmann M; Vogelsang H; Kletter K; Zettinig G; Chott A; Raderer M
    Gut; 2003 Mar; 52(3):347-51. PubMed ID: 12584214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
    Specht JM; Tam SL; Kurland BF; Gralow JR; Livingston RB; Linden HM; Ellis GK; Schubert EK; Dunnwald LK; Mankoff DA
    Breast Cancer Res Treat; 2007 Sep; 105(1):87-94. PubMed ID: 17268819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
    Avril N; Menzel M; Dose J; Schelling M; Weber W; Jänicke F; Nathrath W; Schwaiger M
    J Nucl Med; 2001 Jan; 42(1):9-16. PubMed ID: 11197987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with rhenium-188-perrhenate and iodine-131 of NIS-expressing mammary cancer in a mouse model remarkably inhibited tumor growth.
    Dadachova E; Nguyen A; Lin EY; Gnatovskiy L; Lu P; Pollard JW
    Nucl Med Biol; 2005 Oct; 32(7):695-700. PubMed ID: 16243644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
    van der Hoeven JJ; Krak NC; Hoekstra OS; Comans EF; Boom RP; van Geldere D; Meijer S; van der Wall E; Buter J; Pinedo HM; Teule GJ; Lammertsma AA
    J Clin Oncol; 2004 Apr; 22(7):1253-9. PubMed ID: 15051773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe 18F-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma.
    Murayama C; Kawaguchi AT; Kamijo A; Naito K; Kanazawa M; Tsukada H
    PLoS One; 2017; 12(1):e0170911. PubMed ID: 28125711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.
    Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
    J Nucl Med; 1994 Jan; 35(1):104-12. PubMed ID: 8271030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience with positron emission tomography with 2-fluorine, 18F-2-deoxy-d-glucose used for the diagnosis of malignant breast neoplasms].
    Tiutin L; Fadeev N; Ryzhkova D; Kostenikiv N; Arzumanov A; Savello V; Tlostanova M
    Vestn Rentgenol Radiol; 2001; (6):14-8. PubMed ID: 11858029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
    Lapointe D; Brasseur N; Cadorette J; La Madeleine C; Rodrigue S; van Lier JE; Lecomte R
    J Nucl Med; 1999 May; 40(5):876-82. PubMed ID: 10319764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.